- Ideas
- Markets
- Cryptocurrencies
- Currencies
- Stocks
- Earnings Calendar
- Stock Screener
- Large-Cap
- Top gainers
- Top losers
- Most active
- Most volatile
- Overbought
- Oversold
- All time high
- All time low
- Sector & Industry
LAND SECURITIES GROUP PLC ORD 10 2/3P, BURFORD CAPITAL LIMITED ORD NPV, SXX, BIDSTACK GROUP PLC ORD 0.5P, LLOYDS BANKING GROUP PLC ORD 10P, TCG
- Indices
FTSE 100, DAX Index, Euro Stoxx 50, S&P 500, Nasdaq Composite, Nikkei 225
- Futures
- Bonds
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
- Scripts
- Oscillators
- Centered oscillators
- Volatility
- Trend analysis
- Volume
- Moving average
- Exponential Moving Average (EMA)
- Weighted Moving Average (WMA)
- Simple Moving Average (SMA)
- Hull Moving Average (HMA)
- Kaufman's Adaptive Moving Average (KAMA)
- Smoothed Moving Average (SMMA)
- Variable Index Dynamic Average (VIDYA)
- Volume-weighted Moving Average (VWMA)
- Fractal Adaptive Moving Average (FRAMA)
- Double Exponential Moving Average (DEMA)
- Breadth indicators
- Bill Williams indicators
- Screener
- Brokers
- Chart
- More
IMMUPHARMA PLC ORD 10P
LSE
IMM
IMM
IMMUPHARMA PLC ORD 10P
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
IMM, 1M
All signs look to a dead cat bounce. Obviosuly everyone knows this has been trending down for almost 2 years. This has no consolidation under the 32p resistance, a weekly close under the previous 19p support is not a good look. Very good news was fomo'd into. Next news should be a while, things take time. Get a better entry in the green zone and wait for...
0
Valuation
Enterprise Value/EBITDA, TTM
—
Enterprise Value, FQ
—
Market Cap — Basic
—
Number of Employees
—
Number of Shareholders
—
Price/Earnings, TTM
—
Price/Revenue, TTM
—
Price/Book Ratio, FY
—
Price/Sales Ratio, FY
—
Balance Sheet
Current Ratio, FQ
—
Debt to Equity, FQ
—
Net Debt, FQ
—
Quick Ratio, FQ
—
Total Assets, FQ
—
Total Debt, FQ
—
Operating Metrics
Return on Assets, TTM
—
Return on Equity, TTM
—
Return on Invested Capital, TTM
—
Revenue per Employee, TTM
—
Price History
Average Volume (10 day)
—
Beta - 1 Year
—
Price - 52 Week High
—
Price - 52 Week Low
—
Dividends
Dividends Paid, FY
—
Dividends per Share, FY
—
Expected Annual Dividends
—
Dividends Yield
—
Margins
Net Margin, TTM
—
Gross Margin, TTM
—
Operating Margin, TTM
—
Pretax Margin, TTM
—
Income Statement
Basic EPS, Net Income
—
Earnings per Share, Basic, TTM
—
EBITDA, TTM
—
Gross Profit, FY
—
Last Annual EPS
—
Last Annual Revenue, FY
—
Net Income, FY
—
Total Revenue, FY
—
Free Cash Flow, TTM
—
Sector: Health Technology
Industry: Pharmaceuticals: Other
Employees: ---
ImmuPharma Plc engages in the research, development, and commercialization of pharmaceutical products. Its drug Lupuzor, is a potential treatment for the autoimmune chronic inflammatory disease lupus. The company was founded by Richard Warr and Dimitri F. Dimitriou in 1999 and is headquartered in London, the United Kingdom.
News
Community & tools
For business
© 2020 TradingView
Made with
Made with
Select market data provided by ICE Data Services